Medical Condition News

RSS

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Doctors are increasingly using genetic signatures to diagnose diseases and determine the best course of care, but using DNA sequencing and other techniques to detect genomic rearrangements remains costly or limited in capabilities.

28 Jan 2021

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2, preventing expression of genes that encode proteins in cells such as resident macrophages in the nose and pulmonary alveoli, and epithelial cells lining the alveoli, all of which are entry points for the virus.

28 Jan 2021

Genetically engineered cartilage delivers anti-inflammatory drug in response to knee activity

Working to develop new treatments for osteoarthritis, researchers at Washington University School of Medicine in St. Louis have genetically engineered cartilage to deliver an anti-inflammatory drug in response to activity similar to the bending of a knee or other motions that put stress on joints.

27 Jan 2021

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.

27 Jan 2021

Miniaturized brush tested as a possible technique for loosening cells from walls of pancreatic cysts

In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.

27 Jan 2021

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine, has secured a five-year grant from the National Institutes of Health National Heart, Lung, and Blood Institute.

27 Jan 2021

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

27 Jan 2021

Study uncovers a novel promising target for diabetes treatment

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.

27 Jan 2021

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

27 Jan 2021

Study describes a safe potential therapeutic tool for liver regeneration

A new study led by researchers at the Center for Regenerative Medicine at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) now describes a safe new potential therapeutic tool for the recovery of liver function in chronic and acute liver diseases.

27 Jan 2021

Researchers identify foods that cause 90% of food allergies

The United States Department of Agriculture identifies a group of "big eight" foods that causes 90% of food allergies. Among these foods are wheat and peanuts.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

New study provides both good and bad news about transient ischemic attacks

Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.

27 Jan 2021

Black children have significantly higher rates of shellfish and fish allergies than white children

Black children have significantly higher rates of shellfish and fish allergies than white children, confirming that race plays an important role in how children are affected by food allergies, researchers at Rush University Medical Center have found.

27 Jan 2021

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model

Damage to the brain gray matter plays an important role in the progression of multiple sclerosis. This study now shows that such damage can be caused by inflammatory reactions that lead to loss of synapses, which impairs neural activity.

27 Jan 2021

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT).

27 Jan 2021

Melatonin reduces cysts in the renal tubules of fruit flies

A hormone commonly associated with sleep-wake regulation has been found to reduce cysts in fruit flies, according to Concordia researchers. It's a finding that may affect the way we treat some kidney diseases and reduce the need for kidney transplants.

27 Jan 2021

Medical Condition News

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Genetically engineered cartilage delivers anti-inflammatory drug in response to knee activity

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Miniaturized brush tested as a possible technique for loosening cells from walls of pancreatic cysts

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

Study uncovers a novel promising target for diabetes treatment

RENACER: New national hospital network aims to advance research on brain metastases

Study describes a safe potential therapeutic tool for liver regeneration

Researchers identify foods that cause 90% of food allergies

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

New study provides both good and bad news about transient ischemic attacks

Black children have significantly higher rates of shellfish and fish allergies than white children

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

Melatonin reduces cysts in the renal tubules of fruit flies

New data shows that mINDY gene is involved in blood pressure regulation

New compound could lead to a new class of diabetes drugs

New machine learning tool predicts schizophrenia

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News